Drug Administration Schedule
"Drug Administration Schedule" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
| Descriptor ID |
D004334
|
| MeSH Number(s) |
E02.319.283
|
| Concept/Terms |
Drug Administration Schedule- Drug Administration Schedule
- Administration Schedule, Drug
- Administration Schedules, Drug
- Drug Administration Schedules
- Schedule, Drug Administration
- Schedules, Drug Administration
|
Below are MeSH descriptors whose meaning is more general than "Drug Administration Schedule".
Below are MeSH descriptors whose meaning is more specific than "Drug Administration Schedule".
This graph shows the total number of publications written about "Drug Administration Schedule" by people in this website by year, and whether "Drug Administration Schedule" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 13 | 13 |
| 1996 | 0 | 15 | 15 |
| 1997 | 0 | 9 | 9 |
| 1998 | 0 | 14 | 14 |
| 1999 | 0 | 13 | 13 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 16 | 16 |
| 2002 | 0 | 12 | 12 |
| 2003 | 0 | 20 | 20 |
| 2004 | 0 | 11 | 11 |
| 2005 | 0 | 22 | 22 |
| 2006 | 0 | 30 | 30 |
| 2007 | 0 | 35 | 35 |
| 2008 | 0 | 27 | 27 |
| 2009 | 0 | 21 | 21 |
| 2010 | 0 | 23 | 23 |
| 2011 | 0 | 29 | 29 |
| 2012 | 0 | 26 | 26 |
| 2013 | 0 | 28 | 28 |
| 2014 | 0 | 24 | 24 |
| 2015 | 0 | 18 | 18 |
| 2016 | 0 | 18 | 18 |
| 2017 | 0 | 23 | 23 |
| 2018 | 0 | 28 | 28 |
| 2019 | 0 | 13 | 13 |
| 2020 | 0 | 11 | 11 |
| 2021 | 0 | 9 | 9 |
| 2022 | 0 | 2 | 2 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Administration Schedule" by people in Profiles.
-
Safety of 3-month rifampicin-isoniazid TPT in child household contacts in a community-based intervention. Int J Tuberc Lung Dis. 2025 Feb 01; 29(2):67-74.
-
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer. Expert Rev Anticancer Ther. 2025 Jan; 25(1):27-40.
-
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort. Blood. 2024 Nov 28; 144(22):2360-2363.
-
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6. J Am Acad Dermatol. 2025 Jan; 92(1):68-77.
-
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro Oncol. 2024 May 03; 26(Supplement_2):S155-S164.
-
Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics. Infect Control Hosp Epidemiol. 2024 Jun; 45(6):717-725.
-
Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial. Arthritis Care Res (Hoboken). 2022 03; 74(3):451-460.
-
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet. 2022 02 19; 399(10326):741-755.
-
Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer - an ancillary data analysis of the VELIA trial. Gynecol Oncol. 2022 02; 164(2):278-287.
-
The impact of chemotherapy sequencing on resectable pancreatic cancer by stage. Surg Oncol. 2022 Mar; 40:101694.